Status:
COMPLETED
Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Lyon Civil Hospitals - Lyon Sud Hospital Center
University Hospital, Marseille
Conditions:
COVID 19
Eligibility:
All Genders
Brief Summary
Spectrum of skin lesions may arise during Covid-19 virus infection. It includes non-specific urticaria, aphtoids lesions, but also acrosyndromes, in particular suggestive of chilblains. Pathological f...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Chilblains or vascular abnormalities (Raynaud's phenomenon, purpura, livedo, necrosis, acrocyanosis) of the acral skin (hands, feet, nose, ears) developping during or after a proved or suspected Covid-19 infection.
- Exclusion criteria:
- None
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04361786
Start Date
April 1 2020
End Date
October 30 2020
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295